UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 149 filers reported holding UNIQURE NV in Q2 2019. The put-call ratio across all filers is 0.24 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $478,000 | -7.4% | 25,499 | -7.9% | 0.01% | 0.0% |
Q2 2022 | $516,000 | -40.2% | 27,675 | -42.0% | 0.01% | -44.4% |
Q1 2022 | $863,000 | -22.2% | 47,743 | -10.7% | 0.01% | -25.0% |
Q4 2021 | $1,109,000 | -59.6% | 53,470 | -34.3% | 0.01% | -55.6% |
Q1 2021 | $2,742,000 | -5.5% | 81,401 | +1.3% | 0.03% | -18.2% |
Q4 2020 | $2,903,000 | +39.0% | 80,337 | +41.7% | 0.03% | +6.5% |
Q3 2020 | $2,088,000 | -20.5% | 56,680 | -2.8% | 0.03% | -11.4% |
Q2 2020 | $2,627,000 | -28.7% | 58,307 | -25.0% | 0.04% | -38.6% |
Q1 2020 | $3,687,000 | -40.2% | 77,712 | -9.7% | 0.06% | +18.8% |
Q4 2019 | $6,168,000 | +84.0% | 86,067 | +1.0% | 0.05% | +84.6% |
Q3 2019 | $3,353,000 | -45.3% | 85,178 | +8.5% | 0.03% | -42.2% |
Q2 2019 | $6,133,000 | +15.2% | 78,475 | -12.0% | 0.04% | +18.4% |
Q1 2019 | $5,322,000 | +116.3% | 89,224 | +4.5% | 0.04% | +100.0% |
Q4 2018 | $2,460,000 | – | 85,364 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 841,471 | $15,786,000 | 5.69% |
Nantahala Capital Management | 2,901,929 | $54,440,000 | 3.52% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 544,500 | $10,209,000 | 3.27% |
683 Capital Management, LLC | 1,373,600 | $25,768,000 | 1.99% |
PFM Health Sciences, LP | 2,393,311 | $44,899,000 | 1.62% |
Integral Health Asset Management, LLC | 433,000 | $8,123,000 | 1.58% |
Privium Fund Management B.V. | 238,998 | $4,283,000 | 1.56% |
Nantahala Capital Management | 1,000,000 | $18,760,000 | 1.21% |
Henry James International Management Inc. | 89,469 | $1,678,000 | 0.94% |
Altium Capital Management LP | 105,000 | $1,970,000 | 0.72% |